GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioservo Technologies AB (OSTO:BIOS) » Definitions » Capex-to-Operating-Income

Bioservo Technologies AB (OSTO:BIOS) Capex-to-Operating-Income : 0.00 (As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Bioservo Technologies AB Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Bioservo Technologies AB's Capital Expenditure for the three months ended in Sep. 2023 was kr-0.32 Mil. Its Operating Income for the three months ended in Sep. 2023 was kr-9.76 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Bioservo Technologies AB Capex-to-Operating-Income Historical Data

The historical data trend for Bioservo Technologies AB's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioservo Technologies AB Capex-to-Operating-Income Chart

Bioservo Technologies AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Capex-to-Operating-Income
Get a 7-Day Free Trial - - - - -

Bioservo Technologies AB Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Bioservo Technologies AB's Capex-to-Operating-Income

For the Medical Instruments & Supplies subindustry, Bioservo Technologies AB's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioservo Technologies AB's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioservo Technologies AB's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Bioservo Technologies AB's Capex-to-Operating-Income falls into.



Bioservo Technologies AB Capex-to-Operating-Income Calculation

Bioservo Technologies AB's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-1.053) / -50.572
=N/A

Bioservo Technologies AB's Capex-to-Operating-Income for the quarter that ended in Sep. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.32) / -9.759
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioservo Technologies AB  (OSTO:BIOS) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Bioservo Technologies AB Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Bioservo Technologies AB's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioservo Technologies AB (OSTO:BIOS) Business Description

Traded in Other Exchanges
N/A
Address
Torshamnsgatan 35, Kista, SWE, 164 40
Bioservo Technologies AB is a Sweden based wearable muscle strengthening systems provider company. It develops wearable technologies based on bionic soft robotics. The company offers SEM Gloves, a grip strengthening aid designed for people with impaired hand function or grip-intensive occupations.